I ment those "hoax" cases concerning share price etc. They could not be real for Q3. They did not make any expences yet.
Purdue case is different. It will be real if IPCI sells at least one Rexista pill. But I can't find it happening any time soon. It's useless to put any money on this yet.
We don't even know wether Rexista is going to be accepted or not. If it will not be accepted, we don't have to concern any costs about it.